期刊文献+

Effect of Pioglitazone on Transdifferentiation of Preosteoblasts from Rat Bone Mesenchymal Stem Cells into Adipocytes

Effect of Pioglitazone on Transdifferentiation of Preosteoblasts from Rat Bone Mesenchymal Stem Cells into Adipocytes
下载PDF
导出
摘要 We aimed to examine the effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone marrow mesenchymal stem cells(BMSCs) into adipocytes and investigate its effect on bone metabolism.BMSCs were harvested from the femurs and tibias of a rat,then separated,purified,proliferated for 3 generations and differentiated into preosteoblasts for 5 days and 14 days respectively in the presence of osteogenic medium.Thereafter,the preosteoblasts were cultured for 21 days in the presence of adipogenic medium with and without pioglitazone(1 μg/mL).Partially-differentiated osteoblasts were identified by mineralized nodules with Alizarin red S staining.Transdifferentiated adipocytes were identified by Oil Red O staining.Reverse transcription PCR(RT-PCR) was performed to assay the expression levels of osteogenic markers Runx2 and ALP,and an adipogenic marker PPARγ.Those cells cultured for 5 days did not show mineralized nodules as detected by staining of Alizarin red S,while those cultured for 14 days showed dispersed mineralized centers in the form of brown spots,although without obvious red mineralized nodules.After adipogenic transdifferentiation for 21 days,adipose-drops were found in cells of 5CG and 5EG earlier than those of 14CG and 14EG,and the former showed much more adipocytes separately as detected by Oil Red O staining.Whatever the time was 5 days or 14 days of BMSCs osteogenic differentiation,the cells cultured with pioglitazone showed much more adipocytes than those without pioglitazone.Our experiment showed that the less time it took for BMSCs osteogenic differentiation,a stronger ability remained for BMSCs to transdifferentiate into adipocytes.The mRNA expression levels of Runx2 and ALP were decreased by 1.79 and 1.90 times respectively in 5EG(P< 0.05) as compared with 5CG,and that of PPARγ was increased by 1.31 times in 5EG(P<0.05) as compared with 5CG.The mRNA expression levels of Runx2 and ALP were decreased by 1.45 and 1.54 times respectively in 14EG(P<0.05) as compared with 14CG,and that of PPARγ was increased by 1.39 times in 14EG(P<0.05) as compared with 14CG.It was concluded that pioglitazone stimulated the transdifferentiation of BMSCs into adipocytes.These observations provided a potential mechanism of imbalance in thiazolidinedione induced bone metabolism. We aimed to examine the effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone marrow mesenchymal stem cells(BMSCs) into adipocytes and investigate its effect on bone metabolism.BMSCs were harvested from the femurs and tibias of a rat,then separated,purified,proliferated for 3 generations and differentiated into preosteoblasts for 5 days and 14 days respectively in the presence of osteogenic medium.Thereafter,the preosteoblasts were cultured for 21 days in the presence of adipogenic medium with and without pioglitazone(1 μg/mL).Partially-differentiated osteoblasts were identified by mineralized nodules with Alizarin red S staining.Transdifferentiated adipocytes were identified by Oil Red O staining.Reverse transcription PCR(RT-PCR) was performed to assay the expression levels of osteogenic markers Runx2 and ALP,and an adipogenic marker PPARγ.Those cells cultured for 5 days did not show mineralized nodules as detected by staining of Alizarin red S,while those cultured for 14 days showed dispersed mineralized centers in the form of brown spots,although without obvious red mineralized nodules.After adipogenic transdifferentiation for 21 days,adipose-drops were found in cells of 5CG and 5EG earlier than those of 14CG and 14EG,and the former showed much more adipocytes separately as detected by Oil Red O staining.Whatever the time was 5 days or 14 days of BMSCs osteogenic differentiation,the cells cultured with pioglitazone showed much more adipocytes than those without pioglitazone.Our experiment showed that the less time it took for BMSCs osteogenic differentiation,a stronger ability remained for BMSCs to transdifferentiate into adipocytes.The mRNA expression levels of Runx2 and ALP were decreased by 1.79 and 1.90 times respectively in 5EG(P< 0.05) as compared with 5CG,and that of PPARγ was increased by 1.31 times in 5EG(P<0.05) as compared with 5CG.The mRNA expression levels of Runx2 and ALP were decreased by 1.45 and 1.54 times respectively in 14EG(P<0.05) as compared with 14CG,and that of PPARγ was increased by 1.39 times in 14EG(P<0.05) as compared with 14CG.It was concluded that pioglitazone stimulated the transdifferentiation of BMSCs into adipocytes.These observations provided a potential mechanism of imbalance in thiazolidinedione induced bone metabolism.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2012年第4期530-533,共4页 华中科技大学学报(医学英德文版)
基金 supported by the Doctoral Fund of Ministry of Education of China (No. 200804871155)
关键词 OSTEOGENESIS ADIPOGENESIS PIOGLITAZONE bone metabolism osteogenesis adipogenesis pioglitazone bone metabolism
  • 相关文献

参考文献11

  • 1Moerman EJ,Teng K,Lipschitz DA,et al.Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell . 2004
  • 2Lin TH,Yang RS,Tang CH,et al.PPARgamma inhibitsosteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone . 2007
  • 3Yaturu S,Bryantet B,Jain SK.Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care . 2007
  • 4Rzonca S O,Suva L J,Gaddy D,et al.Bone is a target for the antidiabetic compound rosiglitazone. The Journal of Endocrinology . 2004
  • 5A.A. Ali,R.S. Weinstein,S.A. Stewart,A.M. Parfitt,S.C. Manolagas,R.L. Jilka.Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. The Journal of Endocrinology . 2005
  • 6Ann V S,Deborah E,Eric V,et al.Thiazolidinedione Use and Bone Loss in Older Diabetic Adults. The Journal of Clinical Endocrinology . 2006
  • 7Goldstein BJ.Cliniacal translation of"a diabetes outcome procession trail":ADOPT appropriate combination oral therapies in type 2 diabetes. The Journal of Clinical Endocrinology . 2007
  • 8S Benvenuti,I Cellai,P Luciani,C Deledda,S Baglioni,C Giuliani,R Saccardi,B Mazzanti,S Dal Pozzo,E Mannucci,A Peri,M Serio.Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. Journal of Endocrinological Investigation . 2007
  • 9Soroceanu MA,Miao D,Bai XY,et al.Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. The Journal of Endocrinology . 2004
  • 10Schilling T,N?th U,Klein-Hitpass L,et al.Plasticity in adipogenesisand osteogenesis of human mesenchymal stem cells. Molecular and Cellular Endocrinology . 2007

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部